These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 28815667

  • 1. Diagnostic performance of unenhanced computed tomography and 18 F-fluorodeoxyglucose positron emission tomography in indeterminate adrenal tumours.
    Delivanis DA, Bancos I, Atwell TD, Schmit GD, Eiken PW, Natt N, Erickson D, Maraka S, Young WF, Nathan MA.
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):30-36. PubMed ID: 28815667
    [Abstract] [Full Text] [Related]

  • 2. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
    Okada M, Shimono T, Komeya Y, Ando R, Kagawa Y, Katsube T, Kuwabara M, Yagyu Y, Kumano S, Imaoka I, Tsuchiya N, Ashikaga R, Hosono M, Murakami T.
    Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
    [Abstract] [Full Text] [Related]

  • 3. Adrenal nodules at FDG PET/CT in patients known to have or suspected of having lung cancer: a proposal for an efficient diagnostic algorithm.
    Brady MJ, Thomas J, Wong TZ, Franklin KM, Ho LM, Paulson EK.
    Radiology; 2009 Feb; 250(2):523-30. PubMed ID: 19188319
    [Abstract] [Full Text] [Related]

  • 4. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions.
    Ozcan Kara P, Kara T, Kara Gedik G, Kara F, Sahin O, Ceylan Gunay E, Sari O.
    Nucl Med Commun; 2011 Feb; 32(2):106-12. PubMed ID: 21085046
    [Abstract] [Full Text] [Related]

  • 5. PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients.
    Boland GW, Blake MA, Holalkere NS, Hahn PF.
    AJR Am J Roentgenol; 2009 Apr; 192(4):956-62. PubMed ID: 19304700
    [Abstract] [Full Text] [Related]

  • 6. Performance of 18F-FDG PET/CT in the Characterization of Adrenal Masses in Noncancer Patients: A Prospective Study.
    Guerin C, Pattou F, Brunaud L, Lifante JC, Mirallié E, Haissaguerre M, Huglo D, Olivier P, Houzard C, Ansquer C, Hindié E, Loundou A, Archange C, Tabarin A, Sebag F, Baumstarck K, Taïeb D.
    J Clin Endocrinol Metab; 2017 Jul 01; 102(7):2465-2472. PubMed ID: 28431167
    [Abstract] [Full Text] [Related]

  • 7. FDG-PET and CT characterization of adrenal lesions in cancer patients.
    Jana S, Zhang T, Milstein DM, Isasi CR, Blaufox MD.
    Eur J Nucl Med Mol Imaging; 2006 Jan 01; 33(1):29-35. PubMed ID: 16193311
    [Abstract] [Full Text] [Related]

  • 8. 18F-FDG PET/CT in the evaluation of adrenal masses.
    Metser U, Miller E, Lerman H, Lievshitz G, Avital S, Even-Sapir E.
    J Nucl Med; 2006 Jan 01; 47(1):32-7. PubMed ID: 16391184
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic importance of 18F-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions.
    Ciftci E, Turgut B, Cakmakcilar A, Erturk SA.
    Nucl Med Commun; 2017 Sep 01; 38(9):788-794. PubMed ID: 28692494
    [Abstract] [Full Text] [Related]

  • 10. Incidental non-secreting adrenal masses in cancer patients: intra-individual comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography with computed tomography and shift magnetic resonance imaging.
    Gratz S, Kemke B, Kaiser W, Heinis J, Behr TM, Höffken H.
    J Int Med Res; 2010 Sep 01; 38(2):633-44. PubMed ID: 20515577
    [Abstract] [Full Text] [Related]

  • 11. What parameters from 18F-FDG PET/CT are useful in evaluation of adrenal lesions?
    Kunikowska J, Matyskiel R, Toutounchi S, Grabowska-Derlatka L, Koperski L, Królicki L.
    Eur J Nucl Med Mol Imaging; 2014 Dec 01; 41(12):2273-80. PubMed ID: 25027709
    [Abstract] [Full Text] [Related]

  • 12. Risk stratification of adrenal masses by [18 F]FDG PET/CT: Changing tactics.
    Salgues B, Guerin C, Amodru V, Pattou F, Brunaud L, Lifante JC, Mirallié E, Sahakian N, Castinetti F, Loundou A, Baumstarck K, Sebag F, Taïeb D.
    Clin Endocrinol (Oxf); 2021 Feb 01; 94(2):133-140. PubMed ID: 32978795
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic performance of 18-F-FDG-PET-CT in adrenal lesions using histopathology as reference standard.
    Altinmakas E, Hobbs BP, Ye H, Grubbs EG, Perrier ND, Prieto VG, Lee JE, Ng CS.
    Abdom Radiol (NY); 2017 Feb 01; 42(2):577-584. PubMed ID: 27665482
    [Abstract] [Full Text] [Related]

  • 14. Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography: interim analysis.
    Traugott AL, Dehdashti F, Trinkaus K, Cohen M, Fialkowski E, Quayle F, Hussain H, Davila R, Ylagan L, Moley JF.
    World J Surg; 2010 Jun 01; 34(6):1247-53. PubMed ID: 20140435
    [Abstract] [Full Text] [Related]

  • 15. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI.
    Yun M, Kim W, Alnafisi N, Lacorte L, Jang S, Alavi A.
    J Nucl Med; 2001 Dec 01; 42(12):1795-9. PubMed ID: 11752075
    [Abstract] [Full Text] [Related]

  • 16. Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy--initial experience.
    Blake MA, Slattery JM, Kalra MK, Halpern EF, Fischman AJ, Mueller PR, Boland GW.
    Radiology; 2006 Mar 01; 238(3):970-7. PubMed ID: 16505394
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
    Christensen JA, Nathan MA, Mullan BP, Hartman TE, Swensen SJ, Lowe VJ.
    AJR Am J Roentgenol; 2006 Nov 01; 187(5):1361-7. PubMed ID: 17056930
    [Abstract] [Full Text] [Related]

  • 18. 18F-FDG-PET/CT-based machine learning model evaluates indeterminate adrenal nodules in patients with extra-adrenal malignancies.
    Cao L, Zhang D, Yang H, Xu W, Liu Y.
    World J Surg Oncol; 2023 Sep 26; 21(1):305. PubMed ID: 37749562
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. CT and 18F- FDG-PET-CT Findings in Secondary Adrenal Lymphoma with Pathologic Correlation.
    Altinmakas E, Üçışık-Keser FE, Medeiros LJ, Ng CS.
    Acad Radiol; 2019 Jun 26; 26(6):e108-e114. PubMed ID: 30076085
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.